1. Home
  2. BVS vs ENTA Comparison

BVS vs ENTA Comparison

Compare BVS & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bioventus Inc.

BVS

Bioventus Inc.

HOLD

Current Price

$8.46

Market Cap

482.9M

Sector

Health Care

ML Signal

HOLD

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$13.47

Market Cap

486.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BVS
ENTA
Founded
2011
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
482.9M
486.3M
IPO Year
2016
2012

Fundamental Metrics

Financial Performance
Metric
BVS
ENTA
Price
$8.46
$13.47
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$13.33
$20.40
AVG Volume (30 Days)
285.6K
184.0K
Earning Date
01-01-0001
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
163.46
29.93
EPS
0.33
N/A
Revenue
$568,087,000.00
$102,814,000.00
Revenue This Year
$7.42
$5.91
Revenue Next Year
$6.46
N/A
P/E Ratio
$27.65
N/A
Revenue Growth
N/A
16.48
52 Week Low
$5.81
$4.09
52 Week High
$11.25
$17.15

Technical Indicators

Market Signals
Indicator
BVS
ENTA
Relative Strength Index (RSI) 50.32 44.83
Support Level $6.42 $13.39
Resistance Level $9.01 $13.98
Average True Range (ATR) 0.38 0.86
MACD -0.02 -0.03
Stochastic Oscillator 18.94 15.79

Price Performance

Historical Comparison
BVS
ENTA

About BVS Bioventus Inc.

Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

Share on Social Networks: